Myriad Genetics, Inc. Lease Agreements
13 Contracts & Agreements
- Lease, effective December 7, 2021, between Myriad Women's Health, Inc. and Bayside Area Development, LLC (Filed With SEC on February 28, 2024)
- Lease Agreement, dated February 9, 2022, between Myriad Genetics, Inc. and Bay Bridge/Corporate, LLC (Filed With SEC on February 28, 2024)
- Lease Termination Agreement, dated December 18, 2023, between Myriad Genetics, Inc. and HCPI/Utah II, LLC (Filed With SEC on February 28, 2024)
- Lease Termination Agreement, dated December 18, 2023, between Myriad Genetics, Inc. and HCPI/Utah II, LLC (Filed With SEC on February 28, 2024)
- Lease Termination Agreement, dated December 18, 2023, between the Registrant and HCPI/Utah II, LLC (Filed With SEC on February 28, 2024)
- Lease Agreement, dated January 31, 2019 between the Registrant and Boyer Research Park Associates X, L.C., by its Manager, The Boyer Company, L.C (Filed With SEC on August 13, 2019)
- SECOND AMENDMENT TO LEASE AGREEMENT (Myriad Genetics: Phase IV) (Filed With SEC on May 4, 2016)
- SECOND AMENDMENT TO LEASE (Myriad Genetics: Phase III) (Filed With SEC on May 4, 2016)
- FIFTH AMENDMENT TO LEASE (Myriad Genetics: Phase II) (Filed With SEC on May 4, 2016)
- SIXTH AMENDMENT TO LEASE (Myriad Genetics: Phase I) (Filed With SEC on May 4, 2016)
- AMENDMENT NO. 2 TO SUBLEASE AGREEMENT RESEARCH PARK BUILDING - PHASE V (Filed With SEC on August 12, 2010)
- AMENDMENT NO. 1 TO SUBLEASE AGREEMENT RESEARCH PARK BUILDING - PHASE V (Filed With SEC on August 12, 2010)
- Exhibit 10.4 AMENDMENT TO LEASE AGREEMENT (Myriad Genetics: Phase v) (Filed With SEC on May 5, 2010)
